L

Landmark Bio Tech Stack

Cell and gene therapy manufacturing platform bridging research to clinical production

Biotechnology Research Watertown, Massachusetts 51–200 employees Privately Held

Landmark Bio operates a contract manufacturing service for cell and gene therapies, serving academic researchers through biopharma companies advancing toward IND filings and clinical trials. The hiring mix—senior engineering and research roles dominating across a 51–200-person team—reflects a company scaling manufacturing capabilities: active projects span continuous manufacturing platform development, perfusion cell culture scale-up, and cell bioprinting technology, while pain points center on reducing GMP manufacturing costs and managing vendor spend, indicating operational maturity focused on efficiency rather than early-stage discovery.

Tech Stack 21 technologies

Core StackWindows Server Palo Alto Networks Smartsheet SAP DocuSign Okta CRM qPCR ddPCR Microsoft 365 SharePoint Teams Windows 10 Windows 11 VPN Freshservice Kaseya IT Glue Autotask Veeva Adobe

What Landmark Bio Is Building

◆Challenges

Reducing gmp manufacturing costs
New technology introduction
Vendor cost management

▲Active Projects

Continuous manufacturing platform development
Connected unit operations implementation
New technology introduction
Cell bioprinting towards generating tissue replacements
Maintaining small-scale bioreactors
Scale-up and scale-down of perfusion cell culture processes
Extracellular vesicle process development
Site expansion and lab build-out
New system deployments

Hiring Activity

Accelerating9 roles · 7 in 30d

Department

Engineering

3

Research

3

Manufacturing

1

Ops

1

Sales

1

Seniority

Senior

6

Director

2

Mid

1

Notable leadership hires: CMC Technology Lead

Company intelligence

Find more companies like Landmark Bio by tech stack, pain points and active projects

Get started free

About Landmark Bio

Landmark Bio is a cell and gene therapy contract manufacturing organization based in Watertown, Massachusetts. The company serves three customer segments: academic researchers validating therapeutic targets, physician-scientists preparing IND applications, and biopharma companies advancing pipeline products toward clinical deployment. The service model encompasses process development, manufacturing scale-up, and regulatory support. Current operational activities include managing small-scale bioreactors, optimizing perfusion cell culture workflows, developing extracellular vesicle manufacturing processes, and building out lab infrastructure to support site expansion.

HeadquartersWatertown, Massachusetts

Company Size51–200 employees

Hiring MarketsUnited States

Frequently Asked Questions

What is Landmark Bio's tech stack?

Core tools include Veeva and SAP for manufacturing execution and ERP, Microsoft 365 suite for collaboration, qPCR and ddPCR for quality control, DocuSign for documentation workflows, and Palo Alto Networks infrastructure security. Freshservice and Kaseya handle IT operations.

What is Landmark Bio working on?

Key projects include continuous manufacturing platform development, connected unit operations implementation, perfusion cell culture scale-up and scale-down, cell bioprinting for tissue replacements, extracellular vesicle process development, and lab infrastructure expansion with new system deployments.